In This Article
Omega-3 Benefits: What the Clinical Evidence Actually Shows
Omega-3 fatty acids (EPA and DHA) are backed by one of the largest bodies of evidence in supplement research. Here is what more than 500 clinical trials have established — and what they have not.
Cardiovascular Health (Strong Evidence)
The REDUCE-IT trial (2018, New England Journal of Medicine) is the defining study: 8,179 patients at cardiovascular risk received 4g/day of icosapentaenoic acid (EPA). Result: 25% relative risk reduction in major adverse cardiovascular events vs placebo. The STRENGTH trial with a mixed EPA+DHA formula showed smaller benefit, suggesting EPA may be the more important component for cardiovascular outcomes.
Brain Health and Cognition (Moderate Evidence)
DHA is a major structural component of the brain — making up approximately 97% of the omega-3 content in the brain. Low DHA is associated with cognitive decline, depression, and ADHD. Salem et al. 2001 review: DHA supplementation supports learning and memory in animal models, and multiple human studies show benefits in children with ADHD and in older adults at risk of cognitive decline.
Depression and Mental Health (Moderate Evidence)
Grosso et al. 2014 meta-analysis (PLOS ONE): omega-3 supplementation significantly reduced symptoms of major depressive disorder, with EPA-dominant formulas showing stronger effects. Effect size was moderate — omega-3 appears to work better as an adjunct to treatment than as a standalone intervention for clinical depression.
Inflammation (Strong Mechanistic Evidence)
EPA and DHA are metabolized into anti-inflammatory resolvins and protectins. This is the mechanism behind most of omega-3’s benefits. C-reactive protein (CRP), a marker of systemic inflammation, is consistently reduced in omega-3 supplementation trials.
Eye Health (Strong Evidence)
DHA makes up approximately 93% of the omega-3 fatty acids in the retina. The Age-Related Eye Disease Study 2 (AREDS2) showed reduced risk of advanced age-related macular degeneration with omega-3 supplementation.
The Form Problem (Critical)
Most fish oil on the market is in ethyl ester (EE) form — a synthetic concentrate with low bioavailability. Dyerberg et al. 2010: re-esterified triglyceride (rTG) form showed 124% plasma uptake vs 73% for ethyl ester — a 70% difference. Look for rTG on the label.
Target Dose
2g combined EPA+DHA per day for general health. 4g EPA per day for cardiovascular risk reduction (REDUCE-IT protocol — requires medical supervision). Not total fish oil weight — read the label for actual EPA+DHA content.
Best Omega-3 Supplements (rTG form) Review
All Evidence-Ranked Supplements
Top Rated Supplements
Omega-3 rTG9.5/10Vitamin D3+K29.4/10Magnesium Glycinate9.6/10
All reviews include price comparisons & third-party testing verification
Get the Full 2026 Supplement Dosing Guide
Free — exact doses, forms, and timing for 14 supplements. PubMed-backed.
NordVital Research Team
Evidence-Based Health Research
Our editorial team reviews and fact-checks all supplement content against peer-reviewed research. We follow strict editorial guidelines and only recommend products that meet our evidence standards. Learn about our process →